New Results
Ethacridine inhibits SARS-CoV-2 by inactivating viral particles in cellular models
Xiaoquan Li, Peter Lidsky, Yinghong Xiao, Chien-Ting Wu, Miguel Garcia-Knight, Junjiao Yang, Tsuguhisa Nakayama, Jayakar V. Nayak, Peter K. Jackson, Raul Andino, View ORCID ProfileXiaokun Shu
doi: https://doi.org/10.1101/2020.10.28.359042
Xiaoquan Li
1Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA
2Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, USA
Peter Lidsky
3Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, USA
Yinghong Xiao
3Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, USA
Chien-Ting Wu
4Department of Baxter Laboratory for Stem Cell Biology, Department of Microbiology & Immunology, Stanford University, California, USA
Miguel Garcia-Knight
3Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, USA
Junjiao Yang
1Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA
2Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, USA
Tsuguhisa Nakayama
5Department of Otolaryngology–Head and Neck Surgery, Stanford University, Stanford, California, USA
Jayakar V. Nayak
5Department of Otolaryngology–Head and Neck Surgery, Stanford University, Stanford, California, USA
Peter K. Jackson
4Department of Baxter Laboratory for Stem Cell Biology, Department of Microbiology & Immunology, Stanford University, California, USA
Raul Andino
3Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, USA
Xiaokun Shu
1Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA
2Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, USA
![Loading Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted November 02, 2020.
Ethacridine inhibits SARS-CoV-2 by inactivating viral particles in cellular models
Xiaoquan Li, Peter Lidsky, Yinghong Xiao, Chien-Ting Wu, Miguel Garcia-Knight, Junjiao Yang, Tsuguhisa Nakayama, Jayakar V. Nayak, Peter K. Jackson, Raul Andino, Xiaokun Shu
bioRxiv 2020.10.28.359042; doi: https://doi.org/10.1101/2020.10.28.359042
Ethacridine inhibits SARS-CoV-2 by inactivating viral particles in cellular models
Xiaoquan Li, Peter Lidsky, Yinghong Xiao, Chien-Ting Wu, Miguel Garcia-Knight, Junjiao Yang, Tsuguhisa Nakayama, Jayakar V. Nayak, Peter K. Jackson, Raul Andino, Xiaokun Shu
bioRxiv 2020.10.28.359042; doi: https://doi.org/10.1101/2020.10.28.359042
Subject Area
Subject Areas
- Biochemistry (11745)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14972)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28085)
- Molecular Biology (11592)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7340)
- Zoology (1651)